tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
HUTCHMED (China) Limited (HK:0013)
:0013
Hong Kong Market
0013
HUTCHMED (China)
RESEARCH TOOLSreports

HUTCHMED (China) (0013) Stock News & Sentiment

Compare
7 Followers
HUTCHMED’s Sovleplenib Hits Phase III Goal in Warm Autoimmune Hemolytic Anemia Trial in China
Premium
Company Announcements
HUTCHMED’s Sovleplenib Hits Phase III Goal in Warm Autoimmune Hemolytic Anemia Trial in China
2d ago
HUTCHMED Advances Surufatinib Combo into Phase III Trial for Metastatic Pancreatic Cancer in China
Premium
Company Announcements
HUTCHMED Advances Surufatinib Combo into Phase III Trial for Metastatic Pancreatic Cancer in China
4d ago
HUTCHMED Confirms Total Voting Rights and Share Capital as of Year-End 2025
Premium
Company Announcements
HUTCHMED Confirms Total Voting Rights and Share Capital as of Year-End 2025
9d ago
HUTCHMED Wins Priority Review in China for Savolitinib in MET‑Amplified Gastric Cancer
Premium
Company Announcements
HUTCHMED Wins Priority Review in China for Savolitinib in MET‑Amplified Gastric Cancer
10d ago
HUTCHMED Wins Priority Review in China for Fanregratinib in Second-Line Liver Cancer
Premium
Company Announcements
HUTCHMED Wins Priority Review in China for Fanregratinib in Second-Line Liver Cancer
11d ago
HUTCHMED Launches Global Clinical Trials for Innovative Cancer Therapy
Premium
Company Announcements
HUTCHMED Launches Global Clinical Trials for Innovative Cancer Therapy
23d ago
HUTCHMED Expands Drug Coverage in China’s National and Commercial Insurance Lists
Premium
Company Announcements
HUTCHMED Expands Drug Coverage in China’s National and Commercial Insurance Lists
1M ago
More HK:0013 News >

0013 News on the Web

HUTCHMED Advances Surufatinib Combo into Phase III Trial for Metastatic Pancreatic Cancer in China
TipRanks News
Neutral
CICC Remains a Buy on HUTCHMED (China) (HCM)
TipRanks News
Neutral
Hutchmed enrols last patient in phase three lung cancer trial
ShareCast
Neutral
Hutchmed upbeat on preclinical data for novel cancer therapy
ShareCast
Neutral
HUTCHMED Appoints Johnny Cheng as Acting CEO Amid Leadership Transition
TipRanks News
Neutral
HUTCHMED Successfully Passes All Resolutions at 2025 AGM
TipRanks News
Neutral
Hutchmed China rises 10% as Phase II gastric cancer trial hits key milestone
Proactive Investors
Neutral
HUTCHMED shares rise 10% as Phase II gastric cancer trial hits key milestone
Proactive Investors
Neutral

News Score - Last 7 Days

Neutral
HK:0013
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is HK:0013’s Media Buzz Sentiment?
1 articles about HK:0013 were published this week. In an average week, 1 articles are published.
    What is HK:0013’s weekly average amount of articles?
    In an average week, 1 articles about HK:0013 are published.
      What is HK:0013’s News Sentiment?
      50% of articles about HK:0013 were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        GNPXGenprex
        ARDXArdelyx
        RIGLRigel
        MRKRMarker Therapeutics
        TILInstil Bio
        Showing the stocks with the most bullish news sentiment over the past week